Allegion (NYSE:ALLE) PT Raised to $132.00 at UBS Group

Allegion (NYSE:ALLE) had its price objective lifted by equities researchers at UBS Group from $113.00 to $132.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has a “neutral” rating on the scientific and technical instruments company’s stock. UBS Group’s price target suggests a potential upside of 4.95% from the company’s current price.

Other equities analysts have also recently issued research reports about the company. Mizuho cut Allegion from a “buy” rating to a “neutral” rating and raised their target price for the stock from $140.00 to $141.00 in a report on Friday, February 23rd. StockNews.com upgraded Allegion from a “hold” rating to a “buy” rating in a report on Wednesday, April 10th. Barclays raised their target price on Allegion from $121.00 to $122.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 2nd. Finally, Wells Fargo & Company cut Allegion from an “overweight” rating to an “equal weight” rating and raised their target price for the stock from $139.00 to $140.00 in a report on Wednesday, February 21st. Six equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $127.83.

Allegion Stock Performance

Shares of NYSE:ALLE opened at $125.78 on Tuesday. Allegion has a twelve month low of $95.94 and a twelve month high of $136.91. The firm has a market cap of $11.01 billion, a PE ratio of 20.55, a price-to-earnings-growth ratio of 4.57 and a beta of 1.14. The company has a debt-to-equity ratio of 1.22, a quick ratio of 0.85 and a current ratio of 1.26. The business has a fifty day moving average of $131.06 and a 200-day moving average of $118.65.

Allegion (NYSE:ALLE) last announced its earnings results on Tuesday, February 20th. The scientific and technical instruments company reported $1.68 earnings per share for the quarter, beating analysts’ consensus estimates of $1.59 by $0.09. The company had revenue of $897.40 million during the quarter, compared to analyst estimates of $904.17 million. Allegion had a return on equity of 51.95% and a net margin of 14.80%. The firm’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period last year, the company posted $1.60 earnings per share. On average, equities research analysts predict that Allegion will post 7.01 EPS for the current fiscal year.

Insider Transactions at Allegion

In related news, VP Timothy P. Eckersley sold 5,047 shares of Allegion stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $129.99, for a total value of $656,059.53. Following the sale, the vice president now owns 35,567 shares of the company’s stock, valued at approximately $4,623,354.33. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, VP Timothy P. Eckersley sold 5,047 shares of Allegion stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $129.99, for a total value of $656,059.53. Following the sale, the vice president now owns 35,567 shares of the company’s stock, valued at approximately $4,623,354.33. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Robert C. Martens sold 5,391 shares of Allegion stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $132.84, for a total value of $716,140.44. Following the completion of the sale, the senior vice president now directly owns 7,555 shares in the company, valued at approximately $1,003,606.20. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by insiders.

Institutional Trading of Allegion

A number of institutional investors have recently modified their holdings of ALLE. Raymond James Financial Services Advisors Inc. lifted its position in shares of Allegion by 27.3% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 9,068 shares of the scientific and technical instruments company’s stock valued at $996,000 after acquiring an additional 1,944 shares during the period. American Century Companies Inc. lifted its position in shares of Allegion by 11.8% during the 1st quarter. American Century Companies Inc. now owns 5,825 shares of the scientific and technical instruments company’s stock valued at $639,000 after acquiring an additional 614 shares during the period. HighTower Advisors LLC lifted its position in shares of Allegion by 7.9% during the 1st quarter. HighTower Advisors LLC now owns 6,947 shares of the scientific and technical instruments company’s stock valued at $759,000 after acquiring an additional 510 shares during the period. Private Advisor Group LLC lifted its position in shares of Allegion by 35.2% during the 1st quarter. Private Advisor Group LLC now owns 2,090 shares of the scientific and technical instruments company’s stock valued at $229,000 after acquiring an additional 544 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of Allegion by 88.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,336 shares of the scientific and technical instruments company’s stock worth $366,000 after buying an additional 1,564 shares in the last quarter. 92.21% of the stock is currently owned by institutional investors.

About Allegion

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.